Literature DB >> 15765827

Med-psych drug-drug interactions update. Antiretrovirals, part III: antiretrovirals and drugs of abuse.

Gary H Wynn1, Kelly L Cozza, Michael J Zapor, Glenn W Wortmann, Scott C Armstrong.   

Abstract

The third in a series reviewing the HIV/AIDS antiretroviral drugs, this report summarizes the interactions between antiretrovirals and common drugs of abuse. In an overview format for primary care physicians and psychiatrists, the metabolism and drug interactions in the context of antiretroviral therapy are presented for the following drugs of abuse: alcohol, benzodiazepines, cocaine, GHB (liquid X), ketamine (special K), LSD (acid), MDMA (Ecstasy), opiates, PCP (angel dust), and THC (marijuana).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15765827     DOI: 10.1176/appi.psy.46.1.79

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  14 in total

Review 1.  A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine Products.

Authors:  Andrew Stolbach; Karolina Paziana; Harry Heverling; Paul Pham
Journal:  J Med Toxicol       Date:  2015-09

2.  Clinically significant psychotropic drug-drug interactions in the primary care setting.

Authors:  Brett A English; Marcus Dortch; Larry Ereshefsky; Stanford Jhee
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

3.  Non-injection drug use and HIV disease progression in the era of combination antiretroviral therapy.

Authors:  Aaron M Kipp; Andrew J Desruisseau; Han-Zhu Qian
Journal:  J Subst Abuse Treat       Date:  2011-02-24

4.  Detrimental Effects of Psychotropic Medications Differ by Sex in Aging People With HIV.

Authors:  Swati Mathur; Carla Roberts-Toler; Katherine Tassiopoulos; Karl Goodkin; Milena McLaughlin; Sara Bares; Susan L Koletar; Kristine M Erlandson
Journal:  J Acquir Immune Defic Syndr       Date:  2019-09-01       Impact factor: 3.731

5.  Reducing non-injection drug use in HIV primary care: A randomized trial of brief motivational interviewing, with and without HealthCall, a technology-based enhancement.

Authors:  Efrat Aharonovich; Aaron Sarvet; Malki Stohl; Don DesJarlais; Susan Tross; Teresa Hurst; Antonio Urbina; Deborah Hasin
Journal:  J Subst Abuse Treat       Date:  2016-12-30

Review 6.  Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals.

Authors:  Dhananjay Pal; Deep Kwatra; Mukul Minocha; Durga K Paturi; Balasubrahmanyam Budda; Ashim K Mitra
Journal:  Life Sci       Date:  2010-11-01       Impact factor: 5.037

Review 7.  Methadone, buprenorphine, and street drug interactions with antiretroviral medications.

Authors:  Valerie A Gruber; Elinore F McCance-Katz
Journal:  Curr HIV/AIDS Rep       Date:  2010-08       Impact factor: 5.071

Review 8.  Management of common psychiatric conditions in the HIV-positive population.

Authors:  Kelly Brogan; Joseph Lux
Journal:  Curr HIV/AIDS Rep       Date:  2009-05       Impact factor: 5.071

Review 9.  Antiretroviral medication: an emerging category of prescription drug misuse.

Authors:  Glen P Davis; Hilary L Surratt; Frances R Levin; Carlos Blanco
Journal:  Am J Addict       Date:  2013-09-17

Review 10.  MDR- and CYP3A4-mediated drug-drug interactions.

Authors:  Dhananjay Pal; Ashim K Mitra
Journal:  J Neuroimmune Pharmacol       Date:  2006-08-02       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.